Anbio Biotechnology (NNNN) Enterprise Value (2025)

Anbio Biotechnology has reported Enterprise Value for 1 years, with the latest figure at $4.3 billion in Q4 2025.

• On a quarterly basis, Enterprise Value changed N/A year-over-year to $4.3 billion in Q4 2025; TTM through Dec 2025 was $4.3 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $4.3 billion, changed N/A from the prior year.
• Enterprise Value was $4.3 billion for Q4 2025 at Anbio Biotechnology, down from $4.5 billion in the prior quarter.
• The five-year high for Enterprise Value was $4.5 billion in Q2 2025, with the low at $4.3 billion in Q4 2025.